SERACARE LIFE SCIENCES INC
Healthcare · In Vitro & In Vivo Diagnostic Substances · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | FY09 | |
|---|---|---|---|
| Revenue | $43.5M | $50.4M | $44.4M |
| Operating income | $2.6M | $6.8M | −$15.1M |
| Net income | $2.7M | $6.7M | −$15.4M |
| Total assets | $45.1M | $43.6M | — |
| Total liabilities | $6.5M | $9.1M | — |
| Equity | $38.6M | $34.5M | $26.2M |
| EPS (diluted) | $0.14 | $0.35 | $-0.83 |
| Shares out. | 20.1M | 18.9M | 18.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- 6.0%
- Net margin
- 6.1%
- Return on equity
- 6.9%
- Return on assets
- 5.9%
- Return on capital (ROCE)
- 6.4%
- Liabilities / assets
- 14.4%
- Debt / equity
- 0.17×
- Book value / share
- $1.92
- Revenue growth (YoY)
- −13.7%
- Net income growth (YoY)
- −60.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Altman Z″ (distress)
- 6.20safe
- Accruals / assets
- −2.3%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 5 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Operating margin is positive
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Dec 21, 2007
- NT 10-Kmissed a reporting deadline ↗Dec 14, 2005
- NT 10-Qmissed a reporting deadline ↗Aug 10, 2005
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Murphy Sarah LDirector | Apr 20, 2012 | D | 24,395 | — |
| Nemmers Joseph MDirector | Apr 20, 2012 | D | 8,039 | — |
| Tillman JillDirector | Apr 20, 2012 | D | 23,609 | — |
| Hrusovsky E KevinDirector | Apr 20, 2012 | D | 2,739 | — |
| O'Connor John J. IiOfficer — VP, Sales and Marketing | Apr 20, 2012 | D | 86,880 | — |
| Dilling RonaldOfficer — VP, Operations | Apr 20, 2012 | D | 89,937 | — |
| Benjamin KathleenOfficer — VP, Human Resources | Apr 20, 2012 | D | 40,974 | — |
| Shea KatherynOfficer — VP, BioServices | Apr 20, 2012 | D | 68,990 | — |
| Gould Gregory AOfficer — Interim CEO, CFO, Treas & Sec. | Apr 20, 2012 | D | 237,844 | — |
| Olsen DavidOfficer — VP, Corporate Quality | Apr 20, 2012 | D | 59,938 | — |
| Mclain BrianOfficer — VP, Finance and Controller | Apr 20, 2012 | D | 34,554 | — |
| O'Connor John J. IiOfficer — VP, Sales and Marketing | Mar 25, 2012 | Tax withholding | 3,120 | $3.97 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventApr 25, 2012
- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Shareholder voteApr 24, 2012
- Entered a material agreement · New financial obligationMar 5, 2012
- Entered a material agreementFeb 28, 2012
- Entered a material agreementFeb 14, 2012
- Other material eventFeb 13, 2012
- Results of operationsFeb 10, 2012
- Results of operationsNov 17, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.